【摘 要】
：
Malignant gliomas are resistant to many kinds of treatments including chemotherapy, radiotherapy, and other adjuvant therapies.Autophagy is a novel response of cancer cells to ionizing radiation (IR)
【机 构】
：
Department of Environmental and Occupational Health National Cheng Kung University Medical College T
【出 处】
：
BIT‘s2nd Annual World Cancer Congess-2009 (2009第二届癌症大会)
论文部分内容阅读
Malignant gliomas are resistant to many kinds of treatments including chemotherapy, radiotherapy, and other adjuvant therapies.Autophagy is a novel response of cancer cells to ionizing radiation (IR) or chemotherapy, but its significance and underlying mechanism remains largely elusive.Induction of autophagy in glioma cells using irradiation and arsenic trioxide (ATO) have been reported separately.However, the combined effects of ATO and IR on the cell death processes of malignant glioma cells have not been thoroughly studied, especially in U118-MG cells.In the present study, we investigated the anticancer effect of IR combined with ATO and the underlying mechanisms on U118-MG human malignant glioma cells in vitro.We found that the enhanced cytotoxic effect of IR combined with ATO was through induction of more autophagy in U118-MG cells, which were characterized by the presence of acidic vascular organelle formation, determined by electron microscopic observation and immunoblotting of LC3.Combined treatment could induce more mitotic arrest compared to ATO or IR alone.In addition, we also found that the combined treatment-induced autophagy occurred through inhibition of PI3K/Akt and activation of ERK1/2 signaling pathways.These findings suggest a potential therapeutic strategy for malignant gliomas, which are resistant to various proapoptotic therapies.
其他文献
During the past number of years, the effort of my team has been focused on the identification of genes involved in the malignant progression of prostate cancer.We have used the differential display me
Colorectal cancer (CRC) is one of the commonest cancers wordwide.The risk factors for CRC are both environmental and genetic.Approximately 75% of CRCs are sporadic; the rest are hereditary or belong t
Current immunomagnetic enrichment (IE) method can only detect general epithelial antigens of circulating tumor cells (CTCs).Further characterization of the CTCs to provide specific information on the
Neoadjuvant chemoradiation followed by surgery is standard of care for locally advanced rectal cancer.The impact of pathologic response remains unclear.We reviewed the impact of pathologic response on
Hereditary colorectal cancer syndromes are classified according to the presence of unusually large number of adenomatous or hamartomatous polyps, or their absence.The latter category includes.Lynch sy
A Systematic Review: Non-entry of eligible patients into surgical randomised control trials (RCTs) is the most significant barrier to their success of & the most serious threat to the validity of thei
First line therapy in the treatment of gliomas and malignant melanomas are alkylating agents.These agents induce a dozen of different DNA damages, some of them have been identified to be carcinogenic,
Activation of urokinase-type plasminogen activator (uPA) receptor (uPAR) has been implicated in the initiation of proteolytic, adhesion and signal transduction mechanisms that permit metastasis by col
The usefulness of targeting individual genetic mutations in cancer is limited by the huge variety of cancer genotypes.In contrast, the phenotypes of nearly all solid tumors include a high rate of lact
Serial tomotherapy is a technique that allows slice by slice treatment of intracranial targets using an intensity modulated radio therapeutic algorithm and a Linear Accelerator.In the last 2 years we